Milestone Pharmaceuticals (MIST) announced the acceptance of a Marketing Authorization Application, MAA, by the European Medicines Agency, EMA, ...
European decision on approval is expected by Q1 2027If approved, etripamil nasal spray is expected to offer patients a safe and effective ...
Treating blood pressure with antihypertensives like blood vessel relaxers (ARB drugs) can provide increased life expectancy ...
For patients with hypertension, initiating treatment with an ARB is associated with the best long-term class persistence.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback